If you are:
Possibly Safe: INSUFFICIENT HUMAN AND ANIMAL DATA
Precaution: MAY INHIBIT LACTATION. MOLECULAR WT LOW ENOUGH FOR POSSIBLE EXCRETION.
An adult over 60:
management or monitoring precaution: General-Sustained release dosage form is preferred over immediate release. Neuro/Psych-Anticholinergic effects may cause sedation, hallucinations, confusion, worsen cognitive impairment and increase fall risk. High risk of delirium. Gastrointestinal-May cause or worsen pre-existing constipation. Urogenital-Best avoided in patients with urinary retention from any cause.
Giving oxybutynin Patch, Transdermal Semiweekly to a child under 12:
management or monitoring precaution: Safety and efficacy not established in pediatrics.